
Sign up to save your podcasts
Or
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
4.3
105105 ratings
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
488 Listeners
38 Listeners
9 Listeners
17 Listeners
19 Listeners
13 Listeners
12 Listeners
5 Listeners
6 Listeners
8 Listeners
23 Listeners
90 Listeners
5 Listeners
29 Listeners
14 Listeners
5 Listeners
17 Listeners
2 Listeners
163 Listeners